Garant v. Norfolk Southern Railway Company

CourtDistrict Court, E.D. Michigan
DecidedApril 13, 2020
Docket2:18-cv-12619
StatusUnknown

This text of Garant v. Norfolk Southern Railway Company (Garant v. Norfolk Southern Railway Company) is published on Counsel Stack Legal Research, covering District Court, E.D. Michigan primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Garant v. Norfolk Southern Railway Company, (E.D. Mich. 2020).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION

PATRICK GARANT,

Plaintiff, Case Number 18-12619 v. Honorable David M. Lawson

NORFOLK SOUTHERN RAILWAY CO.,

Defendant. / OPINION AND ORDER GRANTING MOTION FOR SUMMARY JUDGMENT, DISMISSING MOTION TO EXCLUDE EXPERT WITNESS, AND DISMISSING COMPLAINT WITH PREJUDICE Plaintiff Patrick Garant has multiple sclerosis (MS), a chronic, incurable (but treatable) disease that affects the central nervous system. He did not reveal that condition to Norfolk Southern Railway Company when it offered him a job as a train conductor. And when he eventually told a company doctor five years later that he had been taking medication for the disease for several years before the railroad hired him, Norfolk Southern fired him. Garant contends that his termination (and other related actions) violates the Americans with Disabilities Act (ADA). Norfolk Southern says that Garant’s medical condition had nothing to do with the termination; it fired Garant because he lied about it. Because the undisputed facts confirm that Garant was fired for lying, and not due to any discrimination based on an actual or perceived disability, the Court will grant summary judgment to the railroad and dismiss the case. I. In fall 2011, Norfolk Southern offered Garant a position as a railroad conductor. Garant underwent a post-offer physical exam by a physician on November 17, 2011. The physician asked Garant questions and had him fill out a medical questionnaire called a Form MED-15. Garant reviewed and signed the form, certifying that his answers were “true and complete,” and authorizing the release of the information on the form to Norfolk Southern so that it could investigate and confirm the statements on the form. The form contained the ominous warning that if “any answers are untrue or misleading, or material information is omitted,” he could be fired. Garant did not disclose that he had been diagnosed with MS. The MED-15 Form asked whether he had a history of: “Head/Brain injury, disorder or illness;” “Numbness, weakness or

paralysis;” or “Other injuries or illnesses.” Garant checked “No” in response to each. And he listed no “current medications.” In truth, Garant was diagnosed with MS in 2001. His treatments included the prescription drug Tysabri, administered by infusions every four weeks. Garant received this treatment from April 4, 2008, through August 2012. Multiple sclerosis — MS — is a disease in which the insulating covers of nerve cells in the brain and spinal cord — the myelin — are damaged. This damage can disrupt the ability of parts of the nervous system to transmit signals, resulting in a variety of physical symptoms ranging from benign to debilitating. NINDS Multiple Sclerosis Information Page, National Institute of

Neurological Disorders and Stroke (19 November 2015) (http://www.ninds.nih.gov/disorders/ multiple_sclerosis/multiple_sclerosis.htm) (last visited Apr. 10. 2020). Garant testified that his MS does not limit him in any way, and it never affected his ability to do his job. Garant testified that he did not disclose his MS diagnosis or Tysabri use because, at some point, his treating physician, Dr. Julie Burnham, advised him that he did not have to disclose MS on employment applications and that it was his “personal choice” whether to do so. Garant explained that he did not consider MS an illness or injury. He said that he did not consider Tysabri a medication because it was injected, and he equated it with Novocain shots from the dentist. After the post-offer medical exam, Garant was medically cleared to work as a conductor and started on January 30, 2012. He joined the International Association of Sheet Metal, Air, Rail, and Transportation Workers Union, Transportation Division (SMART-TD). His job duties included assembling and uncoupling train cars, moving track switches to align track sections, and applying and releasing hand brakes on cars. Those duties generally involved working on

potentially hazardous, moving equipment in various weather conditions, standing, walking up to three to six miles per shift, frequent climbing and balancing on ladders, and crossing between cars. Garant acknowledged that conductors must be able to recognize and interpret colors on railroad signs and accurately judge distances between stationary and moving cars. Between 2012 and 2015, Garant experienced several medical symptoms, which included seeing sharper and brighter colors in one eye — requiring an eyepatch — and feeling dizzy whenever trains passed by. Garant did not report those conditions to Norfolk Southern. Per federal regulations, Norfolk Southern required Garant to update his medical certification periodically. During Garant’s 2014 recertification exam, he did not disclose his MS diagnosis or symptoms to

the clinician. On May 12, 2017, as part of the medical recertification process, Garant completed a medical questionnaire, which he signed electronically. In response to the question, “[h]ave you taken any prescribed medications in the last 30 days,” Garant checked “yes” and listed “Gilenya,” a prescription medication. In response to another question asking about “[o]ther medical conditions, illnesses and/injuries” cropping up since he completed his last company medical form, Garant listed “MS” since “2001.” He explained that he decided to disclose his MS at that point because he believed Gilenya could affect his laboratory test results. That revelation caught the attention of Kerry Long, a Norfolk Southern medical case coordinator. He asked Dr. Francesca Litow, Norfolk Southern’s chief medical officer, to review Garant’s 2017 questionnaire because Garant listed MS and Gilenya on the form. After reviewing the questionnaire and Norfolk Southern’s files, Dr. Litow concluded that she needed more information about Garant’s reported medical condition and medication.

That same day, Dr. Litow called Garant to obtain more information. The parties disagree, however, about whether Dr. Litow informed Garant at that time that she was pulling him from service. Garant testified, and the defendant concedes, that Dr. Litow did not tell Garant she was pulling him from service. But Garant backed away from his own testimony and adopted Dr. Litow’s position that she did tell him that she was pulling him from service. During the call, Garant confirmed to Dr. Litow that he was diagnosed with MS in 2001 and underwent treatment and evaluations for the condition since that time. Dr. Litow told Garant that she needed to collect more medical information from his doctor. Although Dr. Litow could not recall, Garant said that she remarked that he “would have been better off having diabetes and lying

about it than to have MS.” Garant believed Dr. Litow said this because she was familiar with the medication for diabetes but nor for MS. After the call with Dr. Litow, Long sent Garant a letter listing the medical information needed for Dr. Litow to determine Garant’s fitness for his position and informing him in writing that Norfolk Southern placed him on medical hold. Dr. Litow also asked Long to place Garant on medical hold in the personnel system and to notify Garant’s management team that he was on medical hold. Garant then received a text message removing him from service. After receiving the text, Garant called his trainmaster, Courtney Siffre, reported he was on hold, and asked why Norfolk Southern pulled him from service. Siffre responded that Health Services made the decision, and Garant needed to speak with them to change his status. During the call, Garant also disclosed to Siffre for the first time that he has MS and was taking medication for it. Several days later, Garant received an email from Long requesting records relating to his diagnosis, evaluations, and treatment since 2014. Garant gave Norfolk some of the information

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Texas Department of Community Affairs v. Burdine
450 U.S. 248 (Supreme Court, 1981)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Gross v. FBL Financial Services, Inc.
557 U.S. 167 (Supreme Court, 2009)
King v. PA Consulting Group, Inc.
485 F.3d 577 (Tenth Circuit, 2007)
Lee v. City of Columbus, Ohio
636 F.3d 245 (Sixth Circuit, 2011)
James P. Smith v. Chrysler Corporation
155 F.3d 799 (Sixth Circuit, 1998)
Charlie Dews v. A.B. Dick Company
231 F.3d 1016 (Sixth Circuit, 2000)
Highland Capital, Inc. v. Franklin National Bank
350 F.3d 558 (Sixth Circuit, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
Garant v. Norfolk Southern Railway Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/garant-v-norfolk-southern-railway-company-mied-2020.